S. Finerty

1.7k total citations
36 papers, 1.3k citations indexed

About

S. Finerty is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, S. Finerty has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Epidemiology and 14 papers in Infectious Diseases. Recurrent topics in S. Finerty's work include Viral-associated cancers and disorders (26 papers), Herpesvirus Infections and Treatments (15 papers) and Parvovirus B19 Infection Studies (14 papers). S. Finerty is often cited by papers focused on Viral-associated cancers and disorders (26 papers), Herpesvirus Infections and Treatments (15 papers) and Parvovirus B19 Infection Studies (14 papers). S. Finerty collaborates with scholars based in United Kingdom, United States and Sweden. S. Finerty's co-authors include M. A. Epstein, Andrew Morgan, Alan B. Rickinson, F. T. Scullion, Susan Powell, Beverley J. Randle, James Kirkwood, Dorothy H. Crawford, Anthony J. Morgan and Christos Paraskeva and has published in prestigious journals such as Nature, Science and JNCI Journal of the National Cancer Institute.

In The Last Decade

S. Finerty

36 papers receiving 1.2k citations

Peers

Countries citing papers authored by S. Finerty

Since Specialization

Citations

This map shows the geographic impact of S. Finerty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Finerty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Finerty more than expected).

Fields of papers citing papers by S. Finerty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Finerty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Finerty. The network helps show where S. Finerty may publish in the future.

Co-authorship network of co-authors of S. Finerty

This figure shows the co-authorship network connecting the top 25 collaborators of S. Finerty. A scholar is included among the top collaborators of S. Finerty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Finerty. S. Finerty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus 2001 ·Vaccine ·S. Finerty, Christopher Stokes, Timothy J. Gruffydd-Jones, (unknown), Frances Barr, (unknown)	24
2	Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge 2000 ·Vaccine ·S. Finerty, Christopher Stokes, Timothy J. Gruffydd-Jones, (unknown), (unknown), Christine V. Whiting, W.M.M. Schaaper, Kristian Dalsgaard, (unknown)	15
3	Mucosal infection and vaccination against feline immunodeficiency virus 1999 ·Journal of Biotechnology ·Chris R. Stokes, S. Finerty, T.J. Gruffydd‐Jones, (unknown), D. A. Harbour	13
4	Virus-specific cytotoxic T cell responses are associated with immunity of the cottontop tamarin to Epstein–Barr virus (EBV) 1996 ·Clinical & Experimental Immunology ·A.D. Wilson, (unknown), S. Finerty, P Watkins, Andrew Morgan	18
5	Selection of monoclonal antibodies for the identification of lymphocyte surface antigens in the New World primate Saguinus oedipus oedipus (cotton top tamarin) 1995 ·Journal of Immunological Methods ·A.D. Wilson, (unknown), S. Finerty, P Watkins, Anthony J. Morgan	6
6	Immunization of cottontop tamarins and rabbits with a candidate vaccine against the Epstein-Barr virus based on the major viral envelope glycoprotein gp340 and alum 1994 ·Vaccine ·S. Finerty, M. Mackett, J. R. Arrand, P Watkins, John F. Tarlton, Andrew Morgan	31
7	Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector 1992 ·Journal of General Virology ·S. Finerty, John F. Tarlton, M. Mackett, Michael J. Conway, J. R. Arrand, P Watkins, Andrew Morgan	45
8	Transcriptional expression of the viral genome in the epstein-barr virus-induced tamarin lymphoma and the corresponding lymphoblastoid tumour lines 1992 ·Virus Research ·(unknown), G. Decaussin, S. Finerty, Andrew Morgan, T Ooka	9
9	CpG methylation of viral DNA in EBV‐associated tumours 1990 ·International Journal of Cancer ·Martin J. Allday, (unknown), S. Finerty, Beverly E. Griffin	25
10	Possible involvement of chromosome 1 in in vitro immortalization: Evidence from progression of a human adenoma‐derived cell line in vitro 1989 ·International Journal of Cancer ·Christos Paraskeva, Amanda Harvey, S. Finerty, Susan Powell	31
11	Specific cytogenetic abnormalities in two new human colorectal adenoma-derived epithelial cell lines. 1989 ·PubMed ·Christos Paraskeva, S. Finerty, R A Mountford, Susan Powell	50
12	Validation of a first‐generation epstein‐barr virus vaccine preparation suitable for human use 1989 ·Journal of Medical Virology ·Anthony J. Morgan, A. C. Allison, S. Finerty, F. T. Scullion, Noelene E. Byars, M. A. Epstein	57
13	Prevention of Epstein-Barr (EB) Virus-induced Lymphoma in Cottontop Tamarins by Vaccination with the EB Virus Envelope Glycoprotein gp340 Incorporated into Immune-stimulating Complexes 1988 ·Journal of General Virology ·Andrew Morgan, S. Finerty, Karin Lövgren, F. T. Scullion, Brør Morein	81
14	Immortalization of a human colorectal adenoma cell line by continuous in vitro passage: Possible involvement of chromosome 1 in tumour progression 1988 ·International Journal of Cancer ·(unknown), S. Finerty, Susan Powell	42
15	Burkitt-like lymphoma in an English child: Characterisation of tumour biopsy cells and of the derived tumour cell line 1986 ·British Journal of Cancer ·S. Finerty, Martin Rowe, P J Berry, David Ranson, M.G. Mott, C D Gregory, Alan B. Rickinson	5
16	Endemic Burkitt's Lymphoma: Phenotypic Analysis of Tumor Biopsy Cells and of Derived Tumor Cell Lines2 1986 ·JNCI Journal of the National Cancer Institute ·Cliona M. Rooney, Christopher D. Gregory, Martin Rowe, S. Finerty, C. Edwards, (unknown), A. B. Rickinson	96
17	Individual Tumors of Multifocal EB Virus-Induced Malignant Lymphomas in Tamarins Arise from Different B-Cell Clones 1985 ·Science ·M. L. Cleary, M. A. Epstein, S. Finerty, R. F. Dorfman, G. W. Bornkamm, (unknown), Anthony J. Morgan, Jeffrey Sklar	84
18	Virological and immunological studies on a fatal case of infectious mononucleosis 1979 ·Journal of Infection ·Dorothy H. Crawford, M. A. Epstein, B. G. Achong, S. Finerty, (unknown), (unknown), Richard S. Tedder, J W Stewart	22
19	Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas 1979 ·International Journal of Cancer ·Dorothy H. Crawford, M. A. Epstein, Georg W. Bornkamm, B. G. Achong, S. Finerty, J. L. Thompson	64
20	Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: Origin of transformed cells arising in co‐cultures with foetal lymphocytes 1977 ·International Journal of Cancer ·Alan B. Rickinson, S. Finerty, M. A. Epstein	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact